Programmed cell death (PCD) is a physiological process commonly defined by alterations in nuclear morphology (apoptosis) and/or characteristic stepwise degradation of chromosomal DNA occurring before cytolysis. However, determined characteristics of PCD such as loss in mitochondrial reductase activity or cytolysis can be induced in enucleated cells, indicating cytoplasmic PCD control. Here we report a sequential disregulation of mitochondrial function that precedes cell shrinkage and nuclear fragmentation. A first cyclosporin A-inhibitable step of ongoing PCD is characterized by a reduction of mitochondrial transmembrane potential, as determined by specific fluorochromes (5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbocyanine iodide; 3,3'dihexyloxacarbocyanine iodide). Cytofluorometrically purified cells with reduced mitochondrial transmembrane potential are initially incapable of oxidizing hydroethidine (HE) into ethidium. Upon short-term in vitro culture, such cells acquire the capacity of HE oxidation, thus revealing a second step of PCD marked by mitochondrial generation of reactive oxygen species (ROS). This step can be selectively inhibited by rotenone and ruthenium red yet is not affected by cyclosporin A. Finally, cells reduce their volume, a step that is delayed by radical scavengers, indicating the implication of ROS in the apoptotic process. This sequence of alterations accompanying early PCD is found in very different models of apoptosis induction: glucocorticoid-induced death of lymphocytes, activation-induced PCD of T cell hybridomas, and tumor necrosis factor-induced death of U937 cells. Transfection with the antiapoptotic protooncogene Bcl-2 simultaneously inhibits mitochondrial alterations and apoptotic cell death triggered by steroids or ceramide. In vivo injection of fluorochromes such as 5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbocyanine iodide; 3,3'dihexyloxacarbocyanine iodide; or HE allows for the detection of cells that are programmed for death but still lack nuclear DNA fragmentation. In particular, assessment of mitochondrial ROS generation provides an accurate picture of PCD-mediated lymphocyte depletion. In conclusion, alterations of mitochondrial function constitute an important feature of early PCD. p rogrammed cell death (PCD) 1 is likely to occur during the whole lifetime of higher organisms, including early embryogenesis, to affect any cell type, and to constitute the normal fate of cells (1-3). In spite of its physiological and pathological importance, at least two major problems concerning PCD remain still elusive: (a) an operative definition of PCD, and (b) an efficient system to detect PCD in vivo.
ical alterations (apoptosis) of the nucleus (heterochromatin condensation, nuclear fragmentation, and pyknosis), as well as a stepwise degradation of nuclear DNA, first into subchromosomal fragments of 50-300 kbp, then into mono-or oligonucleosomal DNA fragments (1) (2) (3) . The notion that the nucleus would be a prime target of PCD is supported by a series of observations: (a) direct DNA damage may cause PCD; (b) during apoptosis, nuclear disintegration precedes cytolysis; (c) in numerous experimental systems, a strict correlation between modulation of PCD and nuclear apoptosis is observed; (d) agents that inhibit DNA-degrading enzymes retard cytolysis of cells undergoing PCD; and (e) a number of PCD-regulatory oncogene products function in the nucleus (3, 4) . However, recent studies invalidate the concept that alterations of the nucleus are obligatory events in PCD. Although agents that inhibit endonucleases such as aurintricarboxylic acid, zinc, and calcium chelators retard cytol-),sis in many systems, they do not ultimately prevent cell death (for review see reference 5). More importantly, PCD can be induced in enuchated cells (cytoblasts), provided that PCD is defined by assessing nonnuclear parameters, a process in which reduction of mitochondrial activity precedes loss of membrane integrity and which is inhibited by the antiapoptotic protooncogene product Bcl-2 (6, 7). Therefore, events occurring independently or upstream of nuclear alterations have a major impact in the regulation and/or execution of PCD.
One of the cardinal features of PCD is that, early during the process of death, cells undergo changes of membrane physicochemistry allowing for their recognition and elimination by neighboring cells (8) . The very efficient removal of apoptotic cells in vivo probably accounts for the difficulty of detecting signs of advanced PCD, including signs of nuclear apoptosis, in vivo. This applies particularly to tissues endowed with a high phagocytic capacity, such as peripheral lymphoid organs, yet only partially to organs such as the thymus (9) . Thus, even during drastic apoptosis-inducing regimes, peripheral lymphocytes isolated ex vivo fail to exhibit morphological or biochemical alterations of the nucleus. This has been shown for in vivo injection of lymphocyte-depleting doses of glucocorticoids (10) , superantigens (11) , and certain cytostatic drugs (12) as well as for PCD-inducing HIV infection (13, 14) .
Indirect evidence obtained recently suggests that alterations in mitochondrial physiology could be involved in PCD. First, reactive oxygen species (ROS) may participate as effector molecules in PCD (15) (16) (17) . Although the source of these ROS accounting for PCD execution has not been characterized, it is known that the ubiquinone complex of the respiratory chain is a major source of superoxide radicals (18) . Second, lymphocytes undergoing glucocorticoid or superantigeninduced death, as well as fibroblasts transfected with a temperature-sensitive mutant of SV40 large T cell antigen, exhibit a reduction in mitochondrial transmembrane potential (A~m) preceding nuclear DNA degradation (19, 20) . The reduction in AXItm also concerns peripheral lymphocytes dying from PCD in vivo (19) . Third, in a cell-free system, only mitochondria-enriched cytoplasma fractions are capable of inducing nuclear apoptosis (21) . Fourth, members of the Bcl-2 family of apoptosis-regulatory proteins are located preferentially in the outer mitochondrial membrane (22) , and, at least in one system, localization to this compartment is indispensable for apoptosis modulation (23) .
Stimulated by these observations, we assessed mitochondrial function in preapoptotic cells, i.e., cells that still lack nuclear signs of PCD yet are irreversibly committed to undergoing PCD. We report here that a defined sequence of mitochondrial alterations-reduction of A~m followed by enhanced generation of superoxide anions-is a constant feature of early PCD. The mechanisms accounting for mitochondrial disregulation have been characterized.
Materials and Methods
Animals and In Vivo Manipulations. 6-to 10-wk-old BALB/c females received intraperitoneal injections of dexamethasone (DEX, 1 mg; Sigma Chemical Co., St. Louis, MO) or PBS as a vehicle control (200 #1) (10) . In some experiments, animals received intravenous injections of nontoxic doses of the fluorochromes 5,5;6,6'-tetrachloro-l,l',3,Y-tetraethylbenzimidazolcarbocyanine iodide (JC-1; 380 #M in 200 #1 PBS), 3,Ydihexyloxacarbocyanine iodide (DiOC6(3); 100 #M), and/or hydroethidine (HE; 5 mM; Molecular Probes, Inc., Eugene, OK) 20-30 min before killing.
Cells and Culture Conditions. Splenocytes were prepared on ice, depleted from erythrocytes by hypotonic lysis as described (11) , and maintained in RPMI 1640 medium supplemented with 10% FCS, t-glutamine, Hepes, and antibiotics at 0-4~ until labeling and analysis. 2B4.11 T cell hybridoma cell lines stably transfected with an SFFu vector containing the human bd-2 gene or the neomycin resistance gene only (24, 25) (kindly provided by Jonathan Ashwell, National Institutes of Health), U937 myelomonocytary cells, or WEHI-231 pre-B cells were incubated with the indicated apoptosis-inducing stimulus: 100 #M DEX; 50 #M ceramide (Sigma Chemical Co.) (26) ; plastic-immobilized anti-CD3 (145-2Cll, coated to flat-bottomed 96-weU microtiter plates [Nunc, Koskilde, Denmark] at 20 #g/ml in 100 mM Tris-HCl overnight); human rTNF-cr (0.4 ng/ml; Research Diagnostics, Inc., Flanders, NJ), and/or cycloheximide (CHX, 0.5 gg/ml) (27) ; or anti-IgM antibodies (5 #g/ml goat anti-mouse antiserum, Southern Biotechnology Associates; Birmingham, AL) (28) .
Cytofluorometry and Confocal Microscopy. For in vitro labeling, cells were exposed for 10-15 min at 37~ to JC-1 (1 #M in PBS) (29) , propidium iodide (PI; 5 #g/ml), merocyanine 540 (MC540, 10 gg/ml) (30), 10-N nonyl-acridine orange (NAO; 100 nM, Molecular Probes, Inc.) (31), 2',7'-dichlorofluorescin diacetate (DCFH-DA; 5 #M) (15), DiOC6(3) (40 nM) (32) , and/or HE (2 gM) (33) . As a control in some experiments, cells were labeled in the presence of the uncoupling agent carbonyl cyanide m-chlorophenylhydrazone (mC1CCP, 50 #M; Sigma Chemical Co.). In a further series of control experiments, cells were incubated in the presence of tert-butylhydroperoxide (50 mM, 2 min, RT; Sigma Chemical Co.), menadione (1 mM, 1 h, 37~ Sigma Chemical Co.), rotenone (1 raM, 1.5 h, 37~ or mCICCP (5 #M, 1 h, 37~ washed twice, and labeled with NAO. Unless otherwise indicated, in all experiments involving splenocytes, forward and side scatters were gated on the major population of normal-sized lymphoid cells. The frequency of cells having lost part of their chromosomal DNA (subdiploid ceils) was determined by ethanol permeabilization and PI staining as described (34) . Analyses were performed on a cytofluorometer (Epics Profile; Coulter Corp., Hialeah, FL) or on a confocal microscope (Acas 570; Meridian Instruments, Inc., Okemos, MI).
Functional Studies of Purified Cell Populations. For cytofluorometric purification, splenocytes were first depleted from cellular debris by density gradient (FicoU Hypaque; Pharmacia LKB, Uppsala, Sweden) centrifugation and then labeled with DiOC6(3) plus HE. Lymphocytes with normal size were gated on via the forward light scatter and were sorted immediately on a cytofluorometer (Elite; Becton Dickinson and Co., San Jose, CA; 104 cells per second, windows as in Fig. 2 ) and recovered in complete medium on ice. Cells were incubated in the presence or absence of cyclosporin A (CsA) (10 #M, Sandoz Pharmaceuticals Corp., East Hanover, NJ), rotenone (1 mM), ruthenium red (100 #M), digitonin (1/~M), antimycin A (50/~M), mC1CCP (50/zM), A23187 (2/~M), N-tbutyl-cr-phenylnitrone (50/~M), trolox (230 #M), and t-ascorbate (600/zM, Sigma Chemical Co.) at doses previously determined to give optimal effects. Cells (minimum 20,000 cells per tube) were kept in media supplemented with the indicated reagents for 15 rain at 4~ followed by relabeling with DiOC6(3) plus HE and reanal-),sis on the cytofluorometer.
Results and Discussion
Reduced A $rr, and Enhanced ROS Generation Characterize DEX-primed Splenocytes In Viva Freshly isolated splenocytes from DEX-primed mice exhibit intact DNA, even when recovered during the phase of maximum reduction of splenic cellularity (12 h after injection of 1 mg DEX) (10, 19) . Although these cells lack established signs of nudear PCD, they exhibit a diminution of A'~Irm, as quantitated by means of the fluorochrome JC-1 (Fig. 1, A and B) . JC-1 incorporates into mitochondria, where it either forms monomers (fluorescence in green, 527 nm) or, at high transmembrane potentials, aggregates (fluorescence in red, 590 nm) (29) . As compared with control cells, DEX-primed splenocytes exhibit a reduced JC-1 aggregation, a finding that indicates a drop in AXI/m. Such a staining pattern is obtained when splenocytes are incubated in vitro (15 rain, 37~ in the presence of JC-1. Very similar results are seen when JC-1 labeling is performed in vivo by injecting a nontoxic dose of the fluorochrome into the animal, followed by a phase of in vivo incubation (30 min) and ex vivo fluorescence analysis of freshly isolated cells (Fig. 1 A) . This demonstrates that A'ICm reduction actually does occur in vivo. Interestingly, DEX-primed cells with low A~Ifm display a synchronous reduction of JC-1 aggregation in all mitochondria-containing cytoplasma areas (Fig. 1 B) . Uncoupling of DEX-primed cells with mC1CCP can further reduce JC-1 incorporation into cells by 0.3-0.5 logs (Fig.  1 A) , indicating that the A~m is not completely disrupted.
In a further series of experiments, JC-1 was replaced by another fluorochrome, DiOC6(3), which incorporates into mitochondria in strict nonlinear dependence of A'~I/m and emits exclusively within the spectrum of green light (32) . As reported (19) , staining with DiOC6(3) revealed the presence of a major subpopulation of A~m l~ cells within the spleen of DEX-primed animals (see Figs. 1 C and 3 A). Cells were labeled simultaneously with HE, a substance that is oxidized by ROS to become ethidium (Eth) and to emit red fluorescence (33) . Splenocytes from DEX-primed animals contain two distinct DiOCr(3) l~ (Aff'm 1~ subpopulations, one that exhibits low ROS formation (HE-cells), comparable to that of AXI'mhis h cells, and another one that is characterized by an enhanced HE ~ Eth conversion (HE + cells). The DiOC6 ( Since DEX-primed splenocytes do not stain with 2',7'= dichlorofluorescin diacetate (which measures H202 formation [15, 33, 35] ) (Fig. 2 ) yet become capable of converting HE into Eth (which is especiaUy sensitive to superoxide anions [33, 35] ), it appears that the ROS responsible for HE conversion is superoxide anion.
Minor populations of A~ICm l~ or HE + cells were also found in spleens from unprimed animals ( Fig. 1) , a fact that can be attributed either to cell damage occurring during splenocyte purification or to spontaneous cell death, which is relatively frequent in the spleen (36, 37) . Nonetheless, the frequency of such cells is strongly increased in DEX-treated animals.
Sequential g~ ~F m Reduction and ROS Generation in Preapoptotic Cells.
It may be assumed that DiOCs(3)/HE staining of DEX-primed splenocytes provides a snapshot of different stages of ongoing preapoptosis. To determine the exact precursor-product relationship of these stages, the populations defined by simultaneous labding with DiOCr(3) and HE were purified by cytofluorometric sorting while gating on normal-sized ceils in the forward light scatter (Fig. 3 A) . Transmission electron microscopy revealed no major alterations in nuclear morphology in any of these fractions (not shown). Upon relabeling and reanalysis, purified cells cultured in vitro for 1 h at 37~ but not controls kept at 4~ exhibit characteristic phenotypic alterations. A minor population of A~mhighHE= ceils becomes A~rml~ A fraction of A~ml~ cells acquires a A~ml~ + phenotype. A~ml~ + splenocytes conserve their phenotype with the exception of size; forward scatter analysis reveals that a high percentage of these cells collapses during short-term in vitro culture (Fig. 3 A) and thus exhibits a characteristic of incipient apoptosis (38) . None of the purified populations contains a significant percentage (<2%) of subdiploid cells, as assessed by analysis of the DNA content. In vitro culture, followed by assessment of DNA content, reveals that A~ml~ + cells are the first to undergo nuclear fragmentation, whereas their HE-precursors are comparatively resistant to nuclear DNA loss (Fig. 3 B) . These results provide evidence that DEX-primed splenocytes first reduce their A'~Irm and then hyperproduce ROS, reduce in size, and finally undergo endonucleolysis. Kinetic analysis of DEX-induced splenocyte death corroborates this scenario (Fig. 3 C) , which is not restricted to one particular PCD induction system (see below). It appears that labeling with HE provides a more accurate picture of ongoing cell depletion than assessment of AXlrm by DiOC6(3) or JC-1. Whereas a significant reduction of AXiOm precedes the DEX-driven loss in splenic cellularity, enhanced HE staining is observed only when the number of splenic cells is actually diminishing (Fig. 3 C) .
Different Mechanisms Are Involved in zl ~,~ Reduction and Mitochondrial ROS Generation. The notion that the A~m
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and A~ml~ + phenotypes constitute discrete stages of preapoptosis is underscored by manipulations selectively affecting either the loss in AgCm or the production of ROS (Fig. 4) . FACS| cells were cultured 1 h in the presence of different substances known to affect mitochondrial function, followed by relabeling with DiOC6(3)/HE and reanalysis. In the model of DEX-induced splenocyte apoptoffs, the transition from the Aff'mhighHE -to the A~m I~ state, which normally ensues in in vitro culture at 37"C (Fig. 3 A) , is prevented by CsA. Thus, CsA, an agent previously shown to inhibit the opening of mitochondrial inner membrane megachannds in isolated mitochondria (39) and in anoxia-damaged hepatocytes or myocardial ceils (40, 41) , also inhibits PCD-associated A~'m loss in lymphocytes. This may indicate that, during the initial phase of PCD, A~m reduction involves a mitochondrial permeability transition (PT) mediated by mitochondrial inner membrane megachannels.
Although CsA inhibits Affrm ~ reduction, it does not affect the transition from the A~ml~ -to the A~ml~ + stage. ROS production by A~m l~ cells is selectively blocked by inhibition of mitochondrial electron transport in complex I by rotenone as well as by the hexavalent cation ruthenium red, a specific inhibitor of the mitochondrial calcium uniport (42, 43) . To allow for optimal diffusion of ruthenium red to its site of action, the inner mitochondrial membrane, ceils must be partially permeabilized with digitonin (44). Digitonin does not cause a reduction in Al/m per se, since it only permeabilizes cholesterol-containing membranes (45) and the inner mitochondrial membrane is essentially cholesterol free Figure 1 . Assessment of AC/m in splenic T cells from DEX-primed animals. (A) In vivo assessment of DEX-induced shift in Aa/m. 12 h after intraperitoneal administration of DEX or PBS as vehicle control, animals were injected intravenously with JC-1. After 30 min of in vivo incubation, splenocytes were recovered and subjected to cytoftuorometry while gating on normal sized lymphocytes. As a control, cells were incubated before analysis with mC1CCP (50/~M; 15 min, 37~ an uncoupling agent that completely abolishes the AC/m. In addition, DNA from 2 x 106 splenocytes (S) from PBS-or DEX-primed animals was subjected to gel electrophoresis as described (11), not revealing any DNA degradation among DEX-primed splenocytes (insets). Thymocytes (T), which, in contrast to peripheral lymphocytes, do undergo massive DNA fragmentation in vivo (9) in response to DEX, were included as positive controls. Results are representative of three independent experiments. (B) Confocal microscopy of splenocytes labeled ex vivo. Splenic T cells from animals injected with PBS or DEX as above were stained in vitro with the fluorescence dye JC-1 (1/~M, 15 min, 37~ As a control, cells were labeled with JC-1 in the presence ofmC1CCP (5/~M; 15 min, 37~ (C) Simultaneous in vivo detection of A~m and ROS production. After intraperitoneal application of DEX or PBS (12 h before analysis), animals were injected intravenously with DiOC6(3) and HE (20 min before analysis), respectively, followed by cytofluorometric analysis. Mitochondria were uncoupled with the protonophore mC1CCP, as in/g (46) . Complete uncoupling of mitochondria by addition of the protonophore mC1CCP accelerates KOS production. Similarly, the calcium ionophore A23187 accelerates the transition from the A~mbWHE-to the A~m]~ + stage 9 Therefore, ROS responsible for HE -~ Eth conversion are produced by mitochondria in a calcium-dependent fashion. Accordingly, control substances that affect nonmitochondrial pathways of ROS generation fail to affect the transition from the DiOC6(3)]~ to the DiOC6(3)I~ § stage. This applies to inhibitors of lipoxygenase (10 #M nordihydroguaiaretic add), cycloxygenase (500 #M indomethacin), monoamine oxidase (1.5 mM pargyline), xanthine oxidase (300 #M allopurinol), nitric oxide synthetase (100 #M NG-methyl-targinine), pyrrolidinedithiocarbamate (I00 #M), which stops the Fenton reaction converting HzO2 into superoxide anions, and diphenylene iodonium (0.1/~M), an inhibitor of NADPH oxidase and other flavin oxidases (47) (not shown). In contrast, antimycin A, an agent that leads to increased superoxide anion generation at sites proximal to the complex III of electron transport (48) , enhances the A~ml~ -/A~ml~ + transition (Fig. 4) . This underscores that electron transport is still going on in A~m l~ cells.
At a final level, the shrinkage of A~mI~ + calls is selectively inhibited by substances that suppress mitochondrial ROS generation (rotenone, ruthenium red), as well as by antioxidants such as the vitamin E derivative trolox, alone or in 37~ immediately before cytofluorometric analysis. Purified cells from windows 1-3 were kept for 60 rain at 4~ or 37~ followed by relabeling and reanalysis under identical conditions. Among cells from windows 1 and 2, no significant (<10%) reduction in cell size was observed during 1 h of culture at 37~ (not shown). Accordingly, gating on normal-sized cells was maintained during reanalysis of these populations. In contrast, upon reanalysis of fraction 3, a high portion of cells displayed a temperature- relabeling, and reanalysis (manipulation similar as in Fig. 3 A) . The transition to the immediately posterior stage of preapoptosis is indicated for each subpopulation in different conditions of in vitro culture. Background values obtained in control cultures kept at 4~ (Fig. 3 A) were subtracted from experimental values. Results (• are pooled from five different experiments. Each agent was evaluated at least three times. Ruthenium red was diluted in DMSO (final concentration of 1%). Arrows indicate a significant (P <0.01, Student's t test) increase or decrease of transition processes as compared with controls. combination with t-ascorbate, or the radical scavenger N-tbutyl-oz-phenylnitrone (Fig. 4) . This observation confirms that ROS are PCD effector molecules.
In synthesis, these data indicate that A~m reduction and enhanced mitochondrial ROS generation indeed represent two clearly distinct phases of the preapoptotic process. Only after A~ has dropped are ROS generated and do they participate in the perturbation of mitochondrial membranes (see below), as well as in later manifestations of PCD such as cell shrinkage.
Enhanced R OS Generation Is Accompanied by Local Membrane Perturbation but Precedes Alterations of the Cell Membrane.
To determine whether ROS generated in mitochondria have a direct local impact on mitochondrial membranes, the amount of intact cardiolipin, a molecule restricted to the inner mitochondrial membrane (46, 49) , was determined by means of the fluorochrome NAO. NAO interacts stoichiometrically with intact cardiolipin (1:2) (31), and this interaction is not 372 Mitochondria in Early Apoptosis influenced by the mitochondrial energy state (50) . As shown in Fig. 5 A, only two major populations can be detected in the spleen, one characterized by low HE -~ Eth conversion and normal NAO staining (NAOai# cells) and a second one marked by enhanced HE oxidation and reduced NAO staining. The frequency of HE+NAO l~ cells increases in DEXprimed spleens. Control experiments (Fig. 5 B) demonstrate that the reduction of A~tm by incubation with rotenone does not affect the labeling with NAO. In contrast, incubation of cells with an exogenous source of ROS (tert-butylhydroperoxide) or inducers of ROS generation (menadione or mCICCP) causes a reduction in NAO staining. This reduction is immediate after a short incubation with tert-butylhydro:
peroxide (2 min, Fig. 5 B) or an equivalent concentration of H202 (2 min, not shown), suggesting that it could result from direct cardiolipin oxidation. Thus, the ROS responsible for HE ~ Eth conversion may be suspected of causing an immediate oxidation of mitochondrial compounds. Moreover, the fact that most if not all HE-cells exhibit a normal NAO~s h phenotype (Fig. 5 A) indicates that A~ml~ cells still possess normal inner mitochondrial membranes.
As shown above, DEX-primed splenocytes of normal size contain a significant number of HE + cells (Figs. 1 C, 2, 3 A, and 5 C), which undergo cell shrinkage upon in vitro culture (Fig. 3 B) . In contrast, only comparatively small cells exhibit alterations of the cell membrane that have been reported to accompany PCD: an enhanced cell permeability, as indicated by incorporation of PI (51), and increased labeling with MC540 (30, 52) (Fig. 5 C) . MC540 is thought to measure apoptosis-associated alterations in lipid packaging (30) , such as aberrant exposure of phosphatidylserine residues on the outer leaflet of the membrane (53) mediating the phagocytemediated recognition and removal of apoptotic cells. The fraction of small PI interme~tahish MC540 + splenocytes was increased in DEX-primed animals (Fig. 5 C) .
In synthesis, this set of data suggests that ROS generation causes an immediate damage of the inner mitochondrial membrane, yet it precedes cells shrinkage and associated plasma membrane alterations.
Correlation between Mitochondrial Perturbation and Apoptosis Induction in Different In Vitro Models of PCD Reduction in
A~m and subsequent KOS hyperproduction are observed in several in vitro models of physiological PCD, i.e., models in which nontoxic agents were used to induce PCD in susceptible target cells: TNF-a in U937 cells and anti-IgM in WEHI 231 pre-B cells, as well as CD3 cross-linking in T cell hybridomas (Fig. 6) . Ceramide, a second messenger involved in the mediation of some PCD types (26, 54) , also causes these effects. In all of these systems, alterations in mitochondrial function precede DNA fragmentation and nuclear DNA loss. Thus, it appears that mitochondrial derangement is a constant feature of PCD occurring independently of the PCD-inducing stimulus.
In T cell hybridomas, transfection-enforced hyperexpression of the antiapoptotic protooncogene bcl-2 retards AXifm diminution and ROS generation, as well as subsequent nuclear hypoploidy in response to DEX and ceramide. This finding is in agreement with previous data suggesting a Bcl- 2-mediated reduction of KOS production (16) and/or ROS action (15) during apoptosis. In contrast, Bd-2, which is comparatively inefficient in preventing antigen receptor-induced PCD (24, 25, 28) , does not affect the anti-CD3-triggered A~ reduction, ROS production, and loss in nudear DNA ofT cell hybridomas (Fig. 6 ). This underscores the strict correlation between PCD and mitochondrial alterations. Moreover, these data suggest that AXFm reduction and subsequent ROS 373 Zamzami et al+ generation are involved both in Bcl-2-inhibited and in Bcl-2-resistant pathways of PCD.
Concluding Remarks. In this paper, we decipher a sequence of discrete steps of preapoptosis, i.e., of PCD stages occurring before the nucleus or nuclear DNA are fragmented (Fig.  7) . The first alteration that distinguishes cells induced to undergo PCD from normal cells is a fall in A~m, detectable by reduced labeling with DiOC6(3) or diminished JC-1 aggregation. Thereafter, uncoupled mitochondria hyperproduce superoxide anion (detectable by enhanced HE -~ Eth conversion) and simultaneously exhibit a perturbation of the inner mitochondrial membrane (detectable as reduced labeling with NAO). At this stage, cells still possess a normal size, normal dye exclusion capacity (measured by labeling with PI), and normal cell membrane characteristics (assessed by MC540). These parameters are only affected in a subsequent step of preapoptosis, the last detectable in vivo, which involves near simultaneous cell shrinkage, increase in membrane permeability, and alteration of lipid packaging, yet still intact DNA. When integrated with the data available in the literature, the results reported in this paper strongly suggest that reduction of A~m, concomitant with uncoupling of mitochondrial electron transport and ATP synthesis (20, 55) , causes increased generation of ROS, which, in turn, are important mediators of apoptosis (15) (16) (17) . In accord with this hypoth- esis, direct inhibition of mitochondrial DNA replication, blockade of the respiratory chain, and induction of mitochondrial ROS generation cause PCD in lymphocytes and neurons (15, 37, 56, 57) . Moreover, blockade of mitochondrial protein synthesis with doxycycline as wall as inhibition of mitochondrial electron transport with low doses ofrotenone renders glucocorticoid-resistant cell lines sensitive to PCD induction by DEX (55, 58) . The A~m reduction, which we observe as a constant feature of early PCD, is per se sufficient to impair mitochondrial ATP generation, as well as mitochondrial DNA and protein synthesis (59) . Accordingly, thymocyte PCD is accompanied by a strong inhibition of ATP synthesis (60), as well as by a transcription blockade selectively affecting the entire mitochondrial genome (61) . Taken together, these findings argue in favor of a scenario in which breakdown of mitochondrial function, perturbation of intermediate metabolism, and/or ROS generation are involved in extranuclear PCD control. Each of the phenomena reported in this paper, loss of mitochondrial function and ROS generation, would suffice to entail cell death, thus conveying a pleiotropic effector phase to PCD execution.
It has been shown previously that a human fibroblast cell line selected in EthBr to lose mitochondrial DNA (po cells) could be induced to die from apoptosis in response to staurosporine or growth factor withdrawal (62) . po cells compensate for a respiratory defect via enhanced anaerobic glycolysis and thus rely on the provision of excess glucose or pyruvate. The action of the ADP/ATP translocator to import ATP into mitochondria and/or to succinate dehydrogenase allows for the maintenance of a Agrm that is indistinguishable from that of p + controls (63) , suggesting that, even in pO cells, a normal A~ is indispensable for cell survival. L929 cells lacking mitochondrial DNA (po cells) have been reported to be relatively resistant to the cytotoxic effect of TNF, and this resistance has been attributed to a reduced generation of ROS species (64) . In contrast, po L929 cells die when exposed to (Figs. 3-5) . Moreover, it is confirmed in various in vitro systems of apoptosis induction (Fig. 6 ). a combination of TNF and CHX (64) . In accord with these data, we observed that po U937 cells undergo apoptosis after stimulation with TNF and CHX, although with a certain delay as compared with normal p + controls. Interestingly, p~ U937 cells behave exactly as p+ controls in the sense that they manifest an early Aff'~ loss during the TNF/CHXdriven apoptotic process that precedes DNA fragmentation. In addition, such cells hyperproduce KOS, but at a reduced rate as compared with p+ cells (Marchetti, P., N. Zamzami, M. Castedo, T. Hirsch, and G. Kroemer, manuscript in preparation), in contrast to normal cells (Fig. 4) . This may indicate that the mere loss of mitochondrial function as manifested by a AXIrm 10$S, even when mitochondrial ROS generation is abolished or reduced, can participate in the induction of apoptosis. In accord with this speculation, it has been shown that certain types of PCD, e.g., APO-1/Fas-induced apoptosis, do not require mitochondrial ROS generation (65) .
As to the mechanism of apoptosis-associated mitochondrial disregulation, it is tempting to speculate that PT, a phenomenon that has been studied for decades in isolated mitochondria, might be involved in the early step of mitochondrial disregulation (66) . In numerous systems, PT is partially inhibited by CsA via a mechanism involving a mitochondrial cyclophilin but not calcineurin (39-41, 66, 67) . Similarly, CsA retards the initial phase of mitochondrial disregulation accompanying apoptosis of DEX-primed splenocytes (Fig. 4) and TNF-treated U937 cells (not shown). PT involves opening of mitochondrial megachannels (also termed PT pores) localized in the inner membrane, a concomitant increase in permeability to solutes with molecular masses <1,500 daltons, uncoupling with collapse of Agm, and cessation of ATP synthesis. Interestingly, PT transition has selfamplificatory properties, in the sense that loss of matrix Ca 2+ and glutathione, depolarization of the inner membrane, and increased oxidation of thiols, which result from megachannel opening, themselves increase the megachannel gating potential (39, 42) . This explains how PT can spread in a wavelike fashion through populations of isolated mitochondria (66) . Opening of the PT pores might mark a point of no return during the effector phase of ongoing PCD and could account for the apparent synchronization of A~m loss, which affects all mitochondria within a cell simultaneously. Synchronization of AXIZm lOSS between mitochondria has been observed in lymphocytic PCD (Fig. 1 B) as well in relatively large cells, such as sympathetic neurons undergoing apoptosis after withdrawal of nerve cell growth factor from cultures (Zamzami, N., and P. Marchetti, unpublished observation). Although CsA is an effective inhibitor of A~m loss in short-term experiments (Fig. 4) , CsA fails to maintain mitochondrial functions and thus does not prevent DEXinduced PCD during longer incubation periods (68) . In consequence, additional CsA-resistant mechanisms could participate in apoptotic PT, as has been reported for anoxia-induced hepatocyte injury (41) . Shortly after the Agtm drop, within a few hours (Fig. 3) , superoxide anion radicals are generated by an uncoupled respiratory chain via a process that requires ruthenium red-sensitive calcium cycling (Fig. 4) . Overproduced KOS might irreversibly inactivate mitochondrial electron transport chain components and ATPase (69) . This may explain why HE + cells have an even lower A~m than purified HE-Agtmhis h cells (Fig. 3) . Moreover, KOS produced by mitochondria accelerate cellular shrinkage, one of the first alterations accompanying apoptosis (38) , as indicated by experiments involving radical scavengers (Fig. 4) .
Although FF might be the consequence of multiple different pathways reported to participate in PCD regulation, including an elevation of cytosolic calcium levels (70), oxidation of cellular thiols (67) , or depletion of intracellular glucose stores (71), the exact molecular mechanisms responsible for apoptotic VI" remain elusive. Nonetheless, the present data provide dear evidence that alterations of mitochondrial physiology are a constant feature of very different systems of PCD induction, mark a phase of irreversible commitment to death, precede nuclear apoptosis, and allow for the in vivo detection of ongoing PCD. ROS generated from a partially uncoupled respiratory chain actively participate in the effector phase of PCD, and it is possible that mitochondria form part of the cytoplasmic PCD control instance that has been postulated by several groups (6, 21) . These notions strongly suggest that an addendum should be joined to the current definition of apoptosis: Physiological PCD is a process involving an active shutdown of mitochondrial function.
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